SCOPE is now a member of the BioRN Network SCOPE International AG is proud to announce the membership with BioRN, the science and industry cluster of the Rhine-Main-Neckar region around Heidelberg, one of Germany’s strongest biotech hubs. BioRN is a non-profit network fostering health innovations and serving its members by creating a rich translational ecosystem as [...]
Promising development for clinical studies in Romania The National Agency for Medicines and Medical Devices of Romania (NAMMDR) is established by reorganization of the former National Agency for Medicines and Medical Devices (NAMMD). By strengthening the status of national competent authority in the field of human medicine and medical devices, while operating with an ethical and [...]
FDA Approval for oral contraceptive – teamwork to success SCOPE International AG announces that The US Food and Drug Administration (FDA) has approved the new drug application (NDA) of an oral contraceptive for pregnancy prevention that was developed by one of our clients. SCOPE played a major role throughout the developmental process. The entirety of this [...]
SCOPE International announces successful FDA inspection SCOPE International AG is proud to announce that its subsidiary in the United States, SCOPE International USA, Inc., was successfully inspected by the US Food and Drug Administration in June 2019. The outcome of this FDA inspection is the most recent example of the high-quality results produced by the SCOPE [...]
Spotlight on our Biostatistic expertsand strategic consulting team SCOPE International AG is pleased to announce the appointment of Björn Boße as new head of biostatistics. Together with Dr. Klaus Junge as Senior Biostatisticial Advisor SCOPE International offers an exceptional expertise in biostatistics. Björn and Klaus have both more than 20 years of experience in the pharmaceutical [...]
Adam Braithwaite appointed to the Business Development Team for the US SCOPE International AG is pleased to announce the appointment of Adam Braithwaite as the key contact for Business Development in the US. Adam will join the SCOPE BD team as part of its North American subsidiary, SCOPE International USA, based in Pittsburgh, PA. In his [...]
SCOPE enters partnership with Assolombarda Confindustria SCOPE International Italy is proud to announce the partnership with Assolombarda Confindustria Milano, Monza e Brianza, Lodi, the largest territorial entrepreneurial association in Italy. In particular, SCOPE has joined the pharmaceutical companies group and the “Filiera” Life Sciences. The Filiera provides a framework in which all the companies associated with Assolombarda [...]
Andrew Bradshaw new UK Managing Director SCOPE International AG has announced the appointment of Andrew Bradshaw as the new UK Managing Director for its subsidiary, based in Manchester, UK. Guiding a highly motivated and qualified team, Andrew will be responsible for the strategic development of SCOPE International (UK) Ltd. Graduated in Biomedical Sciences from University of [...]
New Managing Director for North American Operations SCOPE International AG is pleased to announce the appointment of Amy O’Sullivan as the new Managing Director of its North American subsidiary, based in Pittsburgh, Pennsylvania. Guiding SCOPE’s business in our fastest growing market, Amy will take over an essential part of our strategic development and leading a growing [...]
AUTHORIZATION MADE EASY Our clinical trial management system InSIGHT now has an electronic signature feature which allows you to sign and authorize study documents more quickly. This new, easy to use feature allows for controlled, accelerated collection of multiple signatures on one document. The E-Signature functionality features an automatic timestamp to ensure accurate signature dates. It [...]
